Combined administration of A2A receptor antagonist and 5-HT1A/1B receptor agonist reverses neuroinflammation in the 6-OHDA model of Parkinson's disease

被引：0
|
作者：
Pinna, A.
Costa, G.
Serra, M.
Morelli, M.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
ANIMAL-MODELS; DYSKINESIA; A(2A);
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
355
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist
    Pinna, Annalisa
    Costa, Giulia
    Serra, Marcello
    Contu, Liliana
    Morelli, Micaela
    NEUROPHARMACOLOGY, 2021, 196
  • [2] Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor antagonist
    Pinna, A.
    Costa, G.
    Serra, M.
    Morelli, M.
    MOVEMENT DISORDERS, 2019, 34
  • [3] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
    Ramezani, Mahdi
    Shahidi, Siamak
    Afshar, Simin
    Habibi, Parisa
    Hashemi-Firouzi, Nasrin
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
  • [4] Full substitution of the discriminative cue of a 5-HT1A/1B/2C agonist with the combined administration of a 5-HT1B/2C and a 5-HT1A agonist
    Miranda, F
    Orozco, G
    Velazquez-Martínez, DN
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (04): : 303 - 311
  • [5] Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain
    Shalom, G
    Gur, E
    Van de Kar, LD
    Lerer, B
    Newman, ME
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S15 - S16
  • [6] PHARMACOLOGICAL PROFILE OF (-)HT-90B, A NOVEL 5-HT1A RECEPTOR AGONIST 5-HT2 RECEPTOR ANTAGONIST
    UCHIDA, H
    INAGAWA, K
    TAMEDA, C
    MIYAUCHI, T
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (07): : 1201 - 1216
  • [7] Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease
    Afshar, Simin
    Shahidi, Siamak
    Rohani, Ali Haeri
    Asl, Sara Soleimani
    Komaki, Alireza
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 96 : 140 - 147
  • [8] Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease
    Pinna, Annalisa
    Ko, Wai Kin D.
    Costa, Giulia
    Tronci, Elisabetta
    Fidalgo, Camino
    Simola, Nicola
    Li, Qin
    Tabrizi, Mojgan Aghazadeh
    Bezard, Erwan
    Carta, Manolo
    Morelli, Micaela
    MOVEMENT DISORDERS, 2016, 31 (04) : 501 - 511
  • [9] A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease
    Jalewa, Jaishree
    Sharma, Mohit Kumar
    Gengler, Simon
    Holscher, Christian
    NEUROPHARMACOLOGY, 2017, 117 : 238 - 248
  • [10] The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons
    Mos, J
    VanHest, A
    VanDrimmelen, M
    Herremans, AHJ
    Olivier, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (2-3) : 145 - 153
12345